id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-N-1929-0003,FDA,FDA-2023-N-1929,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2024-02-08T05:00:00Z,2024,2,,,2024-02-08T14:37:36Z,2024-02579,0,0,09000064863f244d
FDA-2023-N-1929-0002,FDA,FDA-2023-N-1929,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Orphan Drugs,Notice,30 Day Proposed Information Collection,2023-12-04T05:00:00Z,2023,12,2023-12-04T05:00:00Z,2024-01-04T04:59:59Z,2023-12-04T17:10:48Z,2023-26544,0,0,09000064862e35cb
FDA-2023-N-1929-0001,FDA,FDA-2023-N-1929,Agency Information Collection Activities; Proposed Collection; Comment Request; Orphan Drugs,Notice,60 Day Proposed Information Collection,2023-06-13T04:00:00Z,2023,6,2023-06-13T04:00:00Z,2023-08-15T03:59:59Z,2023-12-04T18:05:34Z,2023-12547,0,0,0900006485b0f465